> 数据图表一起讨论下1 港股医药行业2026上半年业绩总览——全行业表现2026-9-51 港股医药行业2026上半年业绩总览——全行业表现结构分化更加明显，创新药、药店、CXO等板块业绩快速增长 2026H1增速领先：收入：创新药、CXO、疫苗净利润：疫苗、创新药、药店毛利率：创新药、疫苗、化学制剂收入增速归母净利润增速毛利率水平2025全年2025H12026H12025全年2025H12026H12025全年2025H12026H1创新药CXO疫苗药店化学制剂原料药流通医疗服务中药医疗器械全行业（按2026H1收入增速排序）数据来源：iFinD，西南证券整理33.35%16.70%-5.34%21.64%8.46%2.69%-0.20%-5.44%-1.02%6.54%4.49%28.47%12.12%58.86%20.03%2.24%-0.18%-1.55%-4.58%-1.76%5.16%1.99%88.54%37.85%21.56%3.41%7.66%21.93%15.29%6.67%1.57%0.58%-0.19%-5.14%5.19%4.60%39.45%47.78%62.66%242.64%77.61%22.80%-29.67%136.11%15.34%43.58%50.89%503.88%75.45%35.76%14.63%-21.98%7.37%39.22%11.13%-1.43%-9.40%-1.37%23.14%14.81%-7.52%-11.54%-32.24%34.26%18.63%34.32%-21.10%42.45%24.01%25.23%70.57%17.79%8.55%30.17%27.12%55.17%26.69%77.48%43.10%80.24%25.68%70.31%17.58%8.41%29.37%28.08%56.44%26.19%81.07%45.95%75.64%26.53%71.13%17.31%8.38%30.97%25.83%55.14%27.84%5西南证券健康医疗
